SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:DiVA.org:uu-498892"
 

Sökning: onr:"swepub:oai:DiVA.org:uu-498892" > Fibroblast Growth F...

Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases A Mendelian Randomization Study

Donovan, Killian (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.
Herrington, William G. (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.;Churchill Hosp, Oxford Kidney Unit, Oxford, England.
Pare, Guillaume (författare)
McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
visa fler...
Pigeyre, Marie (författare)
McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.
Haynes, Richard (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.;Churchill Hosp, Oxford Kidney Unit, Oxford, England.
Sardell, Rebecca (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.
Butterworth, Adam S. (författare)
Univ Cambridge, Dept Publ Hlth & Primary Care, BHF Cardiovasc Epidemiol Unit, Cambridge, England.
Folkersen, Lasse (författare)
Danish Natl Genome Ctr, Copenhagen, Denmark.
Gustafsson, Stefan (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Molekylär epidemiologi
Wang, Qin (författare)
Baker Heart & Diabet Inst, Syst Epidemiol, Melbourne, Vic, Australia.
Baigent, Colin (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.
Malarstig, Anders (författare)
Karolinska Inst, Dept Med Epidemiol & Biostat, Solna, Sweden.
Holmes, Michael V. (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.;Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.
Staplin, Natalie (författare)
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.;Univ Oxford, Big Data Inst, Li Ka Shing Ctr Hlth Informat & Discovery, Oxford, England.
visa färre...
Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England. Univ Oxford, Nuffield Dept Populat Hlth NDPH, Clin Trial Serv Unit, Oxford, England.;Univ Oxford, Nuffield Dept Populat Hlth NDPH, Epidemiol Studies Unit, Oxford, England.;Univ Oxford, NDPH, Med Res Council Populat Hlth Res Unit, Oxford, England.;Churchill Hosp, Oxford Kidney Unit, Oxford, England. (creator_code:org_t)
Wolters Kluwer, 2023
2023
Engelska.
Ingår i: American Society of Nephrology. Clinical Journal. - : Wolters Kluwer. - 1555-9041 .- 1555-905X. ; 18:1, s. 17-27
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background Fibroblast growth factor-23 (FGF-23) is associated with a range of cardiovascular and noncardiovascular diseases in conventional epidemiological studies, but substantial residual confounding may exist. Mendelian randomization approaches can help control for such confounding.Methods SCALLOP Consortium data of 19,195 participants were used to generate an FGF-23 genetic score. Data from 337,448 UK Biobank participants were used to estimate associations between higher genetically predicted FGF-23 concentration and the odds of any atherosclerotic cardiovascular disease (n=26,266 events), nonatherosclerotic cardiovascular disease (n=12,652), and noncardiovascular diseases previously linked to FGF-23. Measurements of carotid intima-media thickness and left ventricular mass were available in a subset. Associations with cardiovascular outcomes were also tested in three large case-control consortia: CARDIOGRAMplusC4D (coronary artery disease, n=181,249 cases), MEGASTROKE (stroke, n=34,217), and HERMES (heart failure, n=47,309).Results We identified 34 independent variants for circulating FGF-23, which formed a validated genetic score. There were no associations between genetically predicted FGF-23 and any of the cardiovascular or non cardiovascular outcomes. In UK Biobank, the odds ratio (OR) for any atherosclerotic cardiovascular disease per 1-SD higher genetically predicted logFGF-23 was 1.03 (95% confidence interval [95% CI], 0.98 to 1.08), and for any nonatherosclerotic cardiovascular disease, it was 1.01 (95% CI, 0.94 to 1.09). The ORs in the case-control consortia were 1.00 (95% CI, 0.97 to 1.03) for coronary artery disease, 1.01 (95% CI, 0.95 to 1.07) for stroke, and 1.00 (95% CI, 0.95 to 1.05) for heart failure. In those with imaging, logFGF-23 was not associated with carotid or cardiac abnormalities.Conclusions Genetically predicted FGF-23 levels are not associated with atherosclerotic and nonatherosclerotic cardiovascular diseases, suggesting no important causal link.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy